Pharmacological interventions for the treatment of psychological distress in patients with asthma: a systematic review and meta-analysis
- 27 February 2020
- journal article
- review article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 58 (6) , 759-769
Abstract
OBJECTIVE: To evaluate the effectiveness and safety of pharmacological interventions for the treatment of psychological distress in people with asthma. DATA SOURCES: Electronic searches were performed in Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, PubMed/Medline, Embase, PsycInfo, Health Technology Assessment Database and Web of Science (inception to April 2019). STUDY SELECTIONS: Included studies were randomised controlled trials (RCT) or controlled clinical trials investigating the effect of pharmacological interventions for psychological distress in people with asthma. Records were screened and data extracted by two independent authors into standardised pilot-tested extraction templates. Data was analysed according to standard Cochrane methodology and entered into Review Manager Software version 5.3. RESULTS: From 5,689 studies, six RCTs (n = 215) met inclusion criteria and were included in the systematic review, of which four studies were included in the meta-analysis. A meta-analysis of four studies (n = 158) indicated no evidence of an effect for selective serotonin reuptake inhibitors (Citalopram or Escitalopram) on reduction of psychological distress in adult patients with asthma. Similarly, antiepileptic medication (Levetiracetam) was no better than placebo in the treatment of psychological distress in people with asthma. Adverse events were poorly reported across all studies but were slightly increased among intervention participants compared to control participants. CONCLUSIONS: There was great heterogeneity between studies and overall poor methodological quality providing insufficient evidence to make recommendations for or against the use of pharmacotherapy in asthma patients with psychological distress. Further confirmatory trials are warranted to make recommendations for clinical practice.Keywords
This publication has 40 references indexed in Scilit:
- Escitalopram for Severe Asthma and Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept StudyPsychosomatics, 2012
- Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacyThe British Journal of Psychiatry, 2011
- Management of severe asthma in childrenThe Lancet, 2010
- Anxiety is more common in children with asthmaArchives of Disease in Childhood, 2010
- The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulationMolecular Psychiatry, 2009
- Influence of comorbid conditions on asthmaEuropean Respiratory Journal, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- The Prevalence of DSM-IV Anxiety and Depressive Disorders in Youth with Asthma Compared with ControlsJournal of Adolescent Health, 2007
- Anti-inflammatory properties of desipramine and fluoxetineRespiratory Research, 2007
- The Relationship of Asthma and Anxiety DisordersPsychosomatic Medicine, 2004